"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults","Completed","No Results Available","Influenza","Biological: Influenza A/H9N2 vaccine|Drug: MF59 adjuvant","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00133471"
2,"Influenza Immunity Against Pandemic Respiratory Virus","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT00138281"
3,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Influenza virus vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00835926"
4,"Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (Pediatric formulation)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00836953"
5,"Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine|Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307177"
6,"Half vs Full Dose Influenza Vaccine","Completed","No Results Available","Influenza","Biological: Fluzone® (Aventis Pasteur inactivated influenza vaccine)","Pentagon, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT00283283"
7,"Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.","Completed","No Results Available","Influenza","Biological: CAIV-T|Biological: TIV|Biological: Placebo","David M. Radin, MD, Stamford, Connecticut, United States","https://ClinicalTrials.gov/show/NCT00192309"
8,"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children","Completed","No Results Available","Influenza","Biological: CAIV-T 10^7|Biological: CAIVT 10^5|Biological: Placebo|Biological: TIV","Suncoast Clinical Research, Inc., New Port Richey, Florida, United States|Division of Allergy Immunology and Infectious Disease, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00192322"
9,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Johns Hopkins School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00110279"
10,"Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program","Completed","No Results Available","Influenza","Biological: FluMist","Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States|Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00192218"
11,"Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant Hemagglutinin","Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00328107"
12,"Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)","Completed","No Results Available","Influenza","Biological: AV024|Other: Placebo","SFBC International Inc, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT00240877"
13,"Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults","Completed","Has Results","Influenza Disease; Flu","Biological: Influenza Virus Vaccine","Bardstown, Kentucky, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00264576"
14,"Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age","Completed","No Results Available","Influenza","Biological: FluMist","SFBC International, Inc, Miami, Florida, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Kentucky Pediatric / Adult Research, Inc, Bardstown, Kentucky, United States|University of Maryland, School of Medicine, Baltimore, Maryland, United States|Center for Vaccine Development, Saint Louis, Missouri, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Pediatric Clinical Trials International, Columbus, Ohio, United States|Primary Physician's Research Inc., Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center North, Nashville, Tennessee, United States|University of Virginia, Elson Student Health Center, Charlottesville, Virginia, United States|Marshall University Medical Center, Huntington, West Virginia, United States","https://ClinicalTrials.gov/show/NCT00192140"
15,"Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine|Biological: ActHIB|Biological: Pediarix|Biological: Prevnar|Biological: Menomune","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Centennial, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, New Bedford, Massachusetts, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, University Heights, Ohio, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Norristown, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Rydal, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT00129129"
16,"Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine","Completed","No Results Available","Diphtheria|Tetanus|Whooping Cough|Polio|Haemophilus Influenzae Type b","Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)|Biological: Pentacel: DTaP-IPV/Hib","Fayetteville, AR 72703, Arkansas, United States|Jonesboro, AR 72401, Arkansas, United States|Little Rock, AR 72211, Arkansas, United States|Fountain Valley, CA 92708, California, United States|Englewood, CO 80112, Colorado, United States|Norwich, CT 06360, Connecticut, United States|Orlando, FL 32856, Florida, United States|Marietta, GA 30062, Georgia, United States|Chicago, IL 60614, Illinois, United States|Bardstown, KY 40004, Kentucky, United States|Bossier City, LA 71111, Louisiana, United States|Bridgeton, MO 63044, Missouri, United States|Rochester, NY 14620, New York, United States|Chapel Hill, NC 27514, North Carolina, United States|Portland, OR 97201, Oregon, United States|Norristown, PA 19401, Pennsylvania, United States|Pittsburgh, PA 15213, Pennsylvania, United States|Pittsburgh, PA 15241, Pennsylvania, United States|Kingsport, TN 37664, Tennessee, United States|Austin, TX 78758, Texas, United States|Fort Worth, TX 76107, Texas, United States|San Antonio, TX 78205, Texas, United States|Provo, UT 84604, Utah, United States|Spokane, WA 99220, Washington, United States|LaCrosse, WI 54601, Wisconsin, United States|Marshfield, WI 54449, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00662870"
17,"Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™","Completed","Has Results","Diphtheria|Tetanus|Pertussis|Polio|Haemophilus Infection","Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)","Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Oakland, California, United States|Torrance, California, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Boston, Massachusetts, United States|Woburn, Massachusetts, United States|Omaha, Nebraska, United States|Albany, New York, United States|Rochester, New York, United States|Chapel Hill, North Carolina, United States|Sylva, North Carolina, United States|Pittsburgh, Pennsylvania, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Layton, Utah, United States|Vancouver, Washington, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00802867"
